These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 3703282
1. Tetrahydrobiopterin in dystonia: identification of abnormal metabolism and therapeutic trials. LeWitt PA, Miller LP, Levine RA, Lovenberg W, Newman RP, Papavasiliou A, Rayes A, Eldridge R, Burns RS. Neurology; 1986 Jun; 36(6):760-4. PubMed ID: 3703282 [Abstract] [Full Text] [Related]
2. Treatment of dystonia with tetrahydrobiopterin. LeWitt PA, Newman RP, Miller LP, Lovenberg W, Eldridge R. N Engl J Med; 1983 Jan 20; 308(3):157-8. PubMed ID: 6848912 [No Abstract] [Full Text] [Related]
3. Tetrahydrobiopterin administration in biopterin-deficient progressive dystonia with diurnal variation. Fink JK, Ravin P, Argoff CE, Levine RA, Brady RO, Hallett M, Barton NW. Neurology; 1989 Oct 20; 39(10):1393-5. PubMed ID: 2477772 [Abstract] [Full Text] [Related]
4. Effect of tetrahydrobiopterin and 5-hydroxytryptophan on hereditary progressive dystonia with marked diurnal fluctuation: a suggestion of the serotonergic system involvement. Ishida A, Takada G, Kobayashi Y, Toyoshima I, Takai K. Tohoku J Exp Med; 1988 Mar 20; 154(3):233-9. PubMed ID: 3259739 [Abstract] [Full Text] [Related]
5. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Furukawa Y, Nygaard TG, Gütlich M, Rajput AH, Pifl C, DiStefano L, Chang LJ, Price K, Shimadzu M, Hornykiewicz O, Haycock JW, Kish SJ. Neurology; 1999 Sep 22; 53(5):1032-41. PubMed ID: 10496263 [Abstract] [Full Text] [Related]
6. Use of tetrahydropterins in the treatment of hyperphenylalaninemia due to defective synthesis of tetrahydrobiopterin: evidence that peripherally administered tetrahydropterins enter the brain. Kaufman S, Kapatos G, McInnes RR, Schulman JD, Rizzo WB. Pediatrics; 1982 Sep 22; 70(3):376-80. PubMed ID: 7110811 [Abstract] [Full Text] [Related]
7. [Significance of CSF biopterin and neopterin in hereditary progressive dystonia with marked diurnal fluctuation (HPD)--a clue to pathogenesis]. Furukawa Y, Nishi K, Mizuno Y, Narabayashi H. No To Shinkei; 1995 Mar 22; 47(3):261-8. PubMed ID: 7669428 [Abstract] [Full Text] [Related]
8. Clinical role of pteridine therapy in tetrahydrobiopterin deficiency. Smith I, Hyland K, Kendall B. J Inherit Metab Dis; 1985 Mar 22; 8 Suppl 1():39-45. PubMed ID: 3930840 [Abstract] [Full Text] [Related]
9. Pterin abnormalities in dystonia: a metabolic marker with therapeutic implications. LeWitt PA, Miller LP, Levine RA, Lovenberg W, Newman RP, Papavasiliou A, Rayes A, Eldridge R, Burns RS. Adv Neurol; 1988 Mar 22; 50():193-201. PubMed ID: 2456675 [No Abstract] [Full Text] [Related]
10. Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency. Blau N, Bonafé L, Thöny B. Mol Genet Metab; 2001 Mar 22; 74(1-2):172-85. PubMed ID: 11592814 [Abstract] [Full Text] [Related]
11. GTP-cyclohydrolase I gene mutations in hereditary progressive amd dopa-responsive dystonia. Furukawa Y, Shimadzu M, Rajput AH, Shimizu Y, Tagawa T, Mori H, Yokochi M, Narabayashi H, Hornykiewicz O, Mizuno Y, Kish SJ. Ann Neurol; 1996 May 22; 39(5):609-17. PubMed ID: 8619546 [Abstract] [Full Text] [Related]
12. Biopterin synthesis defects: problems in diagnosis. Hoganson G, Berlow S, Kaufman S, Milstien S, Schuett V, Matalon R, Naylor E, Seifert W. Pediatrics; 1984 Dec 22; 74(6):1004-11. PubMed ID: 6150460 [Abstract] [Full Text] [Related]
13. [Biopterin and child neurologic disease]. Shintaku H. No To Hattatsu; 2009 Jan 22; 41(1):5-10. PubMed ID: 19172809 [Abstract] [Full Text] [Related]
14. Low CSF hydroxylase cofactor (tetrahydrobiopterin) levels in inherited dystonia. Williams A, Eldridge R, Levine R, Lovenberg W, Paulson G. Lancet; 1979 Aug 25; 2(8139):410-1. PubMed ID: 89462 [No Abstract] [Full Text] [Related]
15. [The relation between metabolism of biopterin and dystonia-parkinsonism]. Ichinose H, Ohye T, Suzuki T, Inagaki H, Nagatsu T. Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Apr 25; 19(2):85-9. PubMed ID: 10464780 [Abstract] [Full Text] [Related]
16. Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test. Hyland K, Fryburg JS, Wilson WG, Bebin EM, Arnold LA, Gunasekera RS, Jacobson RD, Rost-Ruffner E, Trugman JM. Neurology; 1997 May 25; 48(5):1290-7. PubMed ID: 9153460 [Abstract] [Full Text] [Related]
17. [Dopa-responsive dystonia: clinical, genetic, and biochemical studies]. Furukawa Y. Rinsho Shinkeigaku; 2006 Jan 25; 46(1):19-34. PubMed ID: 16541791 [Abstract] [Full Text] [Related]
18. Dystonia with marked diurnal variation associated with biopterin deficiency. Fink JK, Barton N, Cohen W, Lovenberg W, Burns RS, Hallett M. Neurology; 1988 May 25; 38(5):707-11. PubMed ID: 2452381 [Abstract] [Full Text] [Related]
19. Tyrosine hydroxylase cofactor (tetrahydrobiopterin) in parkinsonism. LeWitt PA, Miller LP, Newman RP, Burns RS, Insel T, Levine RA, Lovenberg W, Calne DB. Adv Neurol; 1984 May 25; 40():459-62. PubMed ID: 6421110 [No Abstract] [Full Text] [Related]
20. Developmental aspects of pteridine metabolism and relationships with phenylalanine metabolism. Dhondt JL, Ardouin P, Hayte JM, Farriaux JP. Clin Chim Acta; 1981 Oct 26; 116(2):143-52. PubMed ID: 7296883 [Abstract] [Full Text] [Related] Page: [Next] [New Search]